Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more
Xylo Technologies Ltd. (XYLO) - Net Assets
Latest net assets as of December 2024: $17.59 Million USD
Based on the latest financial reports, Xylo Technologies Ltd. (XYLO) has net assets worth $17.59 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($37.55 Million) and total liabilities ($19.96 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $17.59 Million |
| % of Total Assets | 46.84% |
| Annual Growth Rate | 25.14% |
| 5-Year Change | -32.85% |
| 10-Year Change | N/A |
| Growth Volatility | 82.86 |
Xylo Technologies Ltd. - Net Assets Trend (2016–2024)
This chart illustrates how Xylo Technologies Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Xylo Technologies Ltd. (2016–2024)
The table below shows the annual net assets of Xylo Technologies Ltd. from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $17.59 Million | -45.77% |
| 2023-12-31 | $32.44 Million | -40.69% |
| 2022-12-31 | $54.69 Million | +6.33% |
| 2021-12-31 | $51.43 Million | +96.35% |
| 2020-12-31 | $26.19 Million | +222.15% |
| 2019-12-31 | $8.13 Million | +0.64% |
| 2018-12-31 | $8.08 Million | +46.60% |
| 2017-12-31 | $5.51 Million | +88.46% |
| 2016-12-31 | $2.92 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Xylo Technologies Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5435089100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Comprehensive Income | $11.30 Million | 62.86% |
| Other Components | $114.32 Million | 635.66% |
| Total Equity | $17.98 Million | 100.00% |
Xylo Technologies Ltd. Competitors by Market Cap
The table below lists competitors of Xylo Technologies Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Humbl Inc
OTCQB:HMBL
|
$6.64 Million |
|
Resonance Health Ltd
AU:RHT
|
$6.64 Million |
|
PT Bank CIMB Niaga Tbk
MU:NKX
|
$6.64 Million |
|
hGears AG
XETRA:HGEA
|
$6.64 Million |
|
NGX Limited
PINK:NGXLF
|
$6.63 Million |
|
South Star Mining Corp
V:STS
|
$6.63 Million |
|
Pancolour Ink Co., Ltd.
TWO:4765
|
$6.63 Million |
|
CHECKIT PLC (P.RE.) LS-05
F:EKC1
|
$6.63 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Xylo Technologies Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 23,576,000 to 17,984,000, a change of -5,592,000 (-23.7%).
- Net loss of 6,027,000 reduced equity.
- New share issuances of 1,588,000 increased equity.
- Other comprehensive income decreased equity by 999,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-6.03 Million | -33.51% |
| Share Issuances | $1.59 Million | +8.83% |
| Other Comprehensive Income | $-999.00K | -5.55% |
| Other Changes | $-154.00K | -0.86% |
| Total Change | $- | -23.72% |
Book Value vs Market Value Analysis
This analysis compares Xylo Technologies Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.20x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $34.01 | $5.07 | x |
| 2017-12-31 | $17.00 | $5.07 | x |
| 2018-12-31 | $7.70 | $5.07 | x |
| 2019-12-31 | $3.43 | $5.07 | x |
| 2020-12-31 | $6.88 | $5.07 | x |
| 2021-12-31 | $4.27 | $5.07 | x |
| 2022-12-31 | $64.21 | $5.07 | x |
| 2023-12-31 | $37.29 | $5.07 | x |
| 2024-12-31 | $24.95 | $5.07 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Xylo Technologies Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -33.51%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -20.19%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 2.09x
- Recent ROE (-33.51%) is above the historical average (-86.53%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -307.94% | -1640.62% | 0.12x | 1.61x | $-9.30 Million |
| 2017 | -46.18% | -544.97% | 0.06x | 1.31x | $-3.10 Million |
| 2018 | -81.67% | -1513.30% | 0.04x | 1.39x | $-7.41 Million |
| 2019 | -211.39% | -5193.41% | 0.02x | 1.99x | $-14.85 Million |
| 2020 | -18.84% | -814.50% | 0.02x | 1.41x | $-6.62 Million |
| 2021 | 13.81% | 67.15% | 0.17x | 1.21x | $1.88 Million |
| 2022 | -25.08% | -10.68% | 0.94x | 2.49x | $-13.73 Million |
| 2023 | -67.97% | -17.47% | 1.44x | 2.71x | $-18.38 Million |
| 2024 | -33.51% | -20.19% | 0.80x | 2.09x | $-7.83 Million |
Industry Comparison
This section compares Xylo Technologies Ltd.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Xylo Technologies Ltd. (XYLO) | $17.59 Million | -307.94% | 1.13x | $6.64 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |